Metabolic syndrome (MS) is an important cardiovascular risk factor. The aim of this study was to evaluate the incidence of MS in an Italian kidney transplant recipient population and its relationship to the incidence of major adverse cardiovascular events (MACE) after renal transplantation
BACKGROUND: The prevalence of metabolic syndrome (MS) in renal transplant recipients (RTR) is still ...
AbstractIntroductionRenal transplant subjects are considered at risk for the development of obesity ...
OBJECTIVE: Kidney transplant recipients (KTRs) are bound to develop cardiovascular disease (CVD), a...
Introduction. Metabolic syndrome (MS) is an important cardiovascular risk factor. The aim of this st...
BACKGROUND: Metabolic syndrome (MS) includes some risk factors for development of diabetes and cardi...
BACKGROUND: Metabolic syndrome (MS) includes some risk factors for development of diabetes and cardi...
International audienceBACKGROUND: Metabolic syndrome (MS) is a known cardiovascular risk factor in t...
INTRODUCTION: Cardiovascular disease (CVD) is a major determinant of mortality in renal transplant r...
Metabolic syndrome (MS) is a cluster of risk factors that predispose to major cardiovascular disease...
The metabolic syndrome is a constellation of clinical abnormalities related to insulin resistance an...
Aim. The aims of this study were to report the prevalence of metabolic syndrome (MS) in a cohort of ...
Metabolic Syndrome is a cluster of risk factors that predispose individuals to major cardiovascular ...
Despite all improvements in transplant medicine, renal transplant patients have a high risk for card...
Chronic renal transplant dysfunction (CRTD) remains a leading cause of renal allograft loss. Evidenc...
Chronic renal transplant dysfunction (CRTD) remains a leading cause of renal allograft loss. Evidenc...
BACKGROUND: The prevalence of metabolic syndrome (MS) in renal transplant recipients (RTR) is still ...
AbstractIntroductionRenal transplant subjects are considered at risk for the development of obesity ...
OBJECTIVE: Kidney transplant recipients (KTRs) are bound to develop cardiovascular disease (CVD), a...
Introduction. Metabolic syndrome (MS) is an important cardiovascular risk factor. The aim of this st...
BACKGROUND: Metabolic syndrome (MS) includes some risk factors for development of diabetes and cardi...
BACKGROUND: Metabolic syndrome (MS) includes some risk factors for development of diabetes and cardi...
International audienceBACKGROUND: Metabolic syndrome (MS) is a known cardiovascular risk factor in t...
INTRODUCTION: Cardiovascular disease (CVD) is a major determinant of mortality in renal transplant r...
Metabolic syndrome (MS) is a cluster of risk factors that predispose to major cardiovascular disease...
The metabolic syndrome is a constellation of clinical abnormalities related to insulin resistance an...
Aim. The aims of this study were to report the prevalence of metabolic syndrome (MS) in a cohort of ...
Metabolic Syndrome is a cluster of risk factors that predispose individuals to major cardiovascular ...
Despite all improvements in transplant medicine, renal transplant patients have a high risk for card...
Chronic renal transplant dysfunction (CRTD) remains a leading cause of renal allograft loss. Evidenc...
Chronic renal transplant dysfunction (CRTD) remains a leading cause of renal allograft loss. Evidenc...
BACKGROUND: The prevalence of metabolic syndrome (MS) in renal transplant recipients (RTR) is still ...
AbstractIntroductionRenal transplant subjects are considered at risk for the development of obesity ...
OBJECTIVE: Kidney transplant recipients (KTRs) are bound to develop cardiovascular disease (CVD), a...